10% Owner of iTeos Therapeutics, Inc. (U.S.: Nasdaq:ITOS), Gadicke Ansbert, sells 17,356 shares worth $598,543
According to iTeos Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 30 04:49 PM, company 10% Owner, Gadicke Ansbert disclosed selling 17,356 shares at a cost of $34.49. At the time of this transaction (Nov 29), this trade was worth $598,543 in total. As of Nov 29, Gadicke Ansbert now owns 4,953,360 shares in total worth about $174,853,608.0.
For the last few recent trades made by iTeos Therapeutics, Inc. (U.S.: Nasdaq:ITOS) 10% Owner, Gadicke Ansbert, we have the following information:
- SEC Form 4 filing: Nov 26: Sold 21,210 shares at the rate of $35.75 per share. Total worth of this trade was $758,282. Total number of shares owned as of Nov 26 were 4,970,716
- SEC Form 4 filing: Nov 22: Sold 35,333 shares at the rate of $37.52 per share. Total worth of this trade was $1,325,817. Total number of shares owned as of Nov 22 were 5,086,210
- SEC Form 4 filing: Nov 23: Sold 33,476 shares at the rate of $36.22 per share. Total worth of this trade was $1,212,340. Total number of shares owned as of Nov 23 were 5,052,734
Posted by
George Daniels
on Tuesday November 30 2021, 10:48 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
